Document:

Exhibit 10.2

 

Guarantee Agreement

(Summary Translation)

 

This Guarantee Agreement (this “Agreement”)
was entered into by the following parties (the “Parties,” and each a “Party”) at No.808 Meeting Room No.
3 Office Building of Guizhou Province Government in Guiyang City, China on July 31, 2016:

 

Party A: Guizhou Taibang Biological Products
Co., Ltd. (“Guizhou Taibang”)

 

Party B: Guiyang Dalin Biologic Technologies
Co., Ltd. (“Guiyang Dalin”)

 

Party C: Guizhou Jie’an Company
(“Jie’an”)

 

Party D: Shenzhen  Yigong Shengda
Technology Co., Ltd. (“YGSD”)

 

Party E: Ding Sheng Xin Finance Guarantee
Co., Ltd. (“DXS”)

 

WHEREAS, Guizhou Taibang, Guizhou Dalin, Jie’an
and YGSD entered into a settlement agreement (the “Settlement Agreement”) on July 31, 2016.

 

NOW THEREFORE, in order to implement the Settlement
Agreement, the Parties, through friendly negotiation, unanimously agree to and execute this Agreement:

 

		1.	If Guizhou Taibang fails to pay
                                         the capital reduction amounts to Jie’an and YGSD within the agreed timeline under
                                         the Settlement Agreement, Guizhou Taibang shall pay to Jie’an and YGSD liquidated
                                         damages in aggregate amount of RMB80 million, equivalent to 19.27% of the total transaction
                                         amount of RMB415 million.

 

		2.	If Jie’an and YGSD fail
                                         to apply to withdraw the legal proceedings or to execute and provide necessary documents
                                         as agreed under the Settlement Agreement, which causes the failure to complete the capital
                                         reduction within two months after effectiveness of the Settlement Agreement, Jie’an
                                         and YGSD shall jointly pay Guizhou Taibang liquidated damages in aggregate amount of
                                         RMB80 million, equivalent to 19.27% of the total transaction amount of RMB415 million.

 

		3.	If Guizhou Taibang fails to complete
                                         the capital reduction within two months after effectiveness of the Settlement Agreement,
                                         Jie’an and YGSD shall return the shareholders’ loans and accrued interests
                                         to Guizhou Taibang within one month.

 

		4.	DSX agrees to be jointly liable,
                                         as guarantor, for liabilities of Jie’an and YGSD in relation to all the obligations
                                         and liabilities of Jie’an and YGSD as provided under the Settlement Agreement until
                                         such time as Jie’an and YGSD fulfill all the obligations under the Settlement Agreement.

 

		5.	This Agreement supplements the
                                         Settlement Agreement.

 

[Signature page follows]

     

     

    

 

Party A: Guizhou Taibang Biological Products
Co., Ltd. (Seal)

 

	/s/
    Yang Gang	(Authorized
    representative)

 

Party B: Guiyang Dalin Biologic Technologies
Co., Ltd. (Seal)

 

	/s/
    Yang Ming	(Authorized
    representative)

 

Party C: Guizhou Jie’an Company
(Seal)

 

	/s/
    Duan Gang	(Authorized
    representative)

 

Party D: Shenzhen Yigong Shengda
Technology Co., Ltd. (Seal)

 

	/s/
    Duan Gang	(Authorized
    representative)

 

Party E: Ding Sheng Xin Finance Guarantee
Co., Ltd. (Seal)

 

	/s/
    Guo Zhenhua	(Authorized
    representative)

 

    2 \ 2Exhibit 10.3

 

CONSULTING AGREEMENT

 

THIS CONSULTING AGREEMENT
(this “Agreement”) is entered into as of this July 1, 2016 (the “Effective Date”) by and between CHINA
BIOLOGIC PRODUCTS, INC., a Delaware corporation (the “Company”) and Mr. Hui (David) Li (hereinafter referred to as
the “Consultant”).

 

WHEREAS, the Company
desires to appoint the Consultant as senior independent consultant to the Company and the Consultant desires to provide consulting
services to the Company.

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants set forth herein, and for other valuable consideration the receipt and sufficiency
of which are acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

 

1.     Senior
Strategic and Investment Consulting Agreement. The Company hereby agrees to employ Consultant as a consultant to perform
the tasks and duties which are set forth on the Description of Duties attached hereto as Exhibit A, together with such additional
duties and tasks upon which the Company and Consultant may agree (the “Consulting Services”) from time to time. The
parties agree and intend that Consultant shall be an independent consultant. The Company shall not supervise Consultant's performance
of services pursuant to this Agreement, but its representatives shall meet from time to time with Consultant to review and discuss
Consultant's progress in performing specified services. Consultant may perform its services during such hours and at such locations
reasonably requested by the Company; provided, however, that if Consultant renders services at the Company's place
of business, Consultant shall observe the Company's normal business hours.

 

2.     Term.
Subject to Section 4 herein, the term of this Agreement shall be 36 months, commencing on the Effective Date (the “Term”)
to July 1, 2019. The Term may be further extended upon mutual agreement by the parties.

 

3.     Compensation.
During the Term of this Agreement, the Company shall be obligated to compensate Consultant as follows:

 

(a)     The
Consultant shall be awarded 15,000 shares of the Company’s restricted stock, which will vest in three equal portions over
36 months with three vesting dates on July 2, 2017, July 2, 2018 and July 2, 2019, respectively. The restricted stock will be evidenced
by a restricted stock agreement as contemplated by the Company’s 2008 Employee Incentive Plan (the “Plan”), in
the form attached hereto as Exhibit B, both of which will govern the restricted stock, notwithstanding any other provision of this
Agreement.  The parties hereby confirm that the Consultant shall remain as an Employee of the Company as such term is defined
in the Plan during the Term of this Agreement.

 

     

     

    

 

(b)     Consultant
hereby expressly and irrevocably release and forever discharges the Company, its officers, directors, employees, agents, counsels,
accountants, affiliates (collectively, the “Releasees”) from any and all claims, demands, judgments, proceedings, causes
of action, orders, obligations, contracts, agreements, liens, accounts, costs and expenses (including attorney’s fees and
court costs), debts and liabilities whatsoever, whether known or unknown, suspected or unsuspected, matured or unmatured, both
at law (including federal and state securities laws) and in equity, which the Consultant or any of the Consultant’s affiliates
and/or heirs now have or have ever had against the Releasees arising out of being an Employee of the Company, except for its rights
to receive the Company’s restricted stock so awarded under this Agreement and the right to receive shares of the Company’s
common stock upon the vesting of such restricted stock as so awarded in accordance with the terms of the Plan and the applicable
restricted stock agreement.

 

(c)      Consultant
hereby acknowledges that he shall be entitled to no compensation for rendering the Consulting Services other than the Company’s
restricted stock so awarded in accordance with Section 3(a) above.

 

4.     EXPENSES.
 The Company will reimburse the Consultant for pre-approved reasonable business related expenses incurred in good faith
in the performance of the Consultant’s duties for the Company. Such payments shall be made by the Company upon submission
by the Consultant of a signed statement itemizing the expenses incurred. Such statement shall be accompanied by sufficient documentary
matter to support the expenditures.

 

5.      Termination.
The Term of this Agreement may be terminated by either party upon thirty (30) days’ prior written notice.

 

6.     Adherence
to Laws. Consultant represents and warrants that in carrying out the Consulting Services and his duties and responsibilities
under this Agreement, he neither will undertake nor cause, nor permit to be undertaken, any activity which either (i) is illegal
under any applicable laws, decrees, rules or regulations or (ii) would have the effect of causing Consultant to be in violation
of any applicable laws, decrees, rules or regulations.

 

7.     Limitation
on Liability; Indemnification. Consultant’s liability for claims based on, or arising out of this Agreement shall
not exceed the amount of all payments actually paid by Company to Consultant. Consultant shall not be liable for any indirect,
special, incidental or consequential damage irrespective of whether Consultant has advance notice of the possibility of such damages.
Company shall defend, indemnify and hold harmless Consultant from and against any and all damages, claims (contract or tort), liability,
and expense whatsoever, including attorneys’ fees and related disbursements, incurred in connection with the Consulting Services
provided by Consultant.

 

     

     

    

 

8.     Amendment
and Waiver. The terms of this Agreement may not be modified other than in a writing signed by the parties. No term or condition
of this Agreement shall be deemed to have been waived, nor shall there be any estoppel against enforcement of any provision of
this Agreement, except by written instrument of the party charged with such waiver or estoppel. No such written waiver shall be
deemed a continuing waiver unless specifically stated therein, and each such waiver shall operate only as to the specific term
or condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than that
specifically waived.

 

9.     Return
of Materials. All documents, whether hard copy or electronic versions, and all data in Consultant’s possession or
kept by Consultant in connection with the consulting services are the exclusive property of Company. Consultant shall return to
Company, or destroy at the request of Company, all property (including hardware, office equipment, keys and the like) and all documents
or other memorializations of Company upon termination of this Agreement, whether or not for cause and whatever the reason and regardless
of whether any party has breached this Agreement. If requested by Company, Consultant will certify in writing such property, documents
and other memorializations of data have been returned or destroyed.

 

10.      Confidentiality.
Consultant agrees to keep confidential any and all nonpublic information regarding the Company obtained through the provision of
the Consulting Services (the “Confidential Information”). Notwithstanding the foregoing and subject to any restriction
under applicable laws, Consultant shall be entitled to (i) disclose the Confidential Information to any of his attorneys or other
professional advisors strictly on a need-to-know basis where such persons or entities are under appropriate non-disclosure obligations
substantially similar to those set forth in this Section 9, and (ii) disclose any Confidential Information if such Confidential
Information has become publicly available (other than by breach of this Agreement). In the event that Consultant is requested by
any governmental authority or becomes legally required to disclose, under applicable laws, any Confidential Information, Consultant
shall to the extent not prohibited by law provide the Company with prompt written notice of that fact (or where prior disclosure
is not permitted, as soon as practicably possible after such disclosure) and shall consult with the Company regarding such disclosure.
Consultant shall, to the extent possible and with the cooperation and reasonable efforts of the Company, seek a protective order,
confidential treatment or other appropriate remedy. In such event, Consultant shall furnish only that portion of the information
which is legally required to be disclosed and shall exercise reasonable efforts to obtain reliable assurance that confidential
treatment will be accorded such information.

 

     

     

    

 

11.     Notices.
All notices, demands, consents or other communications required or permitted hereunder shall be in writing and shall be deemed
to have been given when personally delivered, sent postage prepaid by registered or certified mail, return receipt requested, such
receipt showing delivery to have been made, or sent overnight by prepaid receipt courier to the address of the parties set forth
on the signature page hereof, or to such other addresses as may hereafter be furnished in writing by the respective parties if
given in the manner required above.

 

12.     Entire
Agreement. This Agreement, together with the exhibits hereto, incorporate the entire understanding among the parties relating
to the subject matter hereof, recites the sole consideration for the promises exchanged and supersedes any prior agreements between
Consultant and the Company with respect to the subject matter hereof. In reaching this Agreement, neither party has relied upon
any representation or promise except those set forth herein.

 

13.     No
Assignment. Neither this Agreement, nor any right or interest hereunder, shall be assignable by Consultant, his beneficiaries
or his legal representatives, without the prior written consent of the Company. Except as required by applicable law, no right
to receive payments under this Agreement shall be subject to anticipation, commutation, alienation, sale, assignment, encumbrance,
charge, pledge or hypothecation or to execution, attachment, levy or similar process of assignment by operation of law, and any
attempt, voluntary or involuntary, to effect any such action shall be null, void and of no effect.

 

14.     Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard
to any otherwise applicable principle of conflicts of laws except as they maybe preempted by, or in conflict with, any federal
laws, rules, regulations or regulatory action.

 

15.     Counterparts/Facsimile.
This Agreement may be executed by either of the parties hereto on any number of separate counterparts and all of said counterparts
taken together shall be deemed to constitute one and the same instrument. This Agreement may be executed by facsimile.

 

16.     Company
Actions. Consultant acknowledges that in any action by the Company to enforce the provisions of this Agreement, claims
asserted by Consultant against the Company arising out of this Agreement shall not constitute a defense to enforcement of Consultant’s
obligations hereunder.

 

17.     Non-Competition.
During the course of the Term hereof, Consultant shall not without the prior approval of the Company engage or be concerned or
interested directly or indirectly as principal, agent, employee or otherwise (except in his capacity employed hereunder) in the
similar business or activities being carry on by the Company or be personally employed or engaged with or without any consideration
in any capacity whatsoever in or in connection with any business whatsoever other than the business of the Company.

 

[Signature Page Follows]

 

     

     

    

 

IN WITNESS WHEREOF, the parties hereto have
caused this Agreement to be duly executed and signed as of the day and year first above written.

 

	 	CHINA BIOLOGIC PRODUCTS, INC.
	 	 	 	 
	 	By:  	/s/ David Gao	 
	 	David Gao
	 	Chairman & Chief Executive Officer
	 	 	 	 
	 	CONSULTANT
	 	 	 	 
	 	 	/s/ David
    Li	 
	 	David Li
	 	 	 	 
	 	Address:	 
	 	 	 	 
	 	 	 	 

 

     

     

    

 

EXHIBIT A

Description of Duties

 

Consultant will mainly assist the Company and management on matters,
including, but limited to:

 

		1.	advise CEO on the Company’s short-term and long-term strategies setting;

 

		2.	advise on potential merger and acquisition transactions;

 

		3.	advise on potential transactions including strategic partnership, technology partnership, joint ventures and alliances; and

 

		4.	assist CEO in potential financial and capital market activities.

 

     

     

    

 

EXHIBIT
B

Form
of Restricted Stock Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00260-of-00352.parquet"}]]